0001214659-22-000265.txt : 20220104
0001214659-22-000265.hdr.sgml : 20220104
20220104182030
ACCESSION NUMBER: 0001214659-22-000265
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORRIS TIMOTHY E
CENTRAL INDEX KEY: 0001191286
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35798
FILM NUMBER: 22508252
MAIL ADDRESS:
STREET 1: ACELRX PHARMACEUTICALS, INC.
STREET 2: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANIGEN, INC
CENTRAL INDEX KEY: 0001293310
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770557236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650.243.3100
MAIL ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20040609
4
1
marketforms-54935.xml
PRIMARY DOCUMENT
X0306
4
2021-12-31
0001293310
HUMANIGEN, INC
HGEN
0001191286
MORRIS TIMOTHY E
C/O HUMANIGEN, INC.
533 AIRPORT BOULEVARD, SUITE 400
BURLINGAME
CA
94010
false
true
false
false
COO and CFO
Stock Option (Right to Buy)
3.72
2021-12-31
4
A
false
51000
0
A
2022-03-31
2031-12-30
Common Stock
51000
51000
D
The option vests in 12 ratable quarterly installments commencing March 31, 2022.
/s/ Timothy Morris
2022-01-04